Is Aurinia Pharmaceuticals' Management Its Best Asset?

Richard Glickman was the founder and CEO of Aspreva Pharmaceuticals a small company that he sold for 915 million in 2008 after it developed CellCept a treatment that today is commonly used in lupus nephritis LN patients Nowadays Glickman s at it again as the founder and CEO